The new 0.5mL single-dose, prefilled syringe has the same composition as the original 2-vial presentation but removes the need for reconstitution. The Food and Drug Administration (FDA) has approved a ...

Please provide your email address to receive an email when new articles are posted on . The Advisory Committee on Immunization Practices recently released its 2018 adult immunization schedule, which ...

The Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Fluarix Quadrivalent (quadrivalent inactivated “split virus” influenza vaccine; ...

GSK has received the Food and Drug Administration’s approval for a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).

Drug launches come with an array of challenges, and GlaxoSmithKline is experiencing that firsthand with its U.S. shingles vaccine rollout. While Shingrix sales are churning ahead of ...

Common side effects of the second dose of the Shingrix vaccine include pain, swelling, and fever. Some side effects are more likely to occur after the second dose than after the first dose. Share on ...

Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate administration Co-administration of the RSV and shingles adjuvanted vaccines was ...

(RTTNews) - British drug maker GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration has accepted for review the regulatory application of a prefilled syringe presentation of ...

Sign up for the CommonHealth newsletter to receive a weekly digest of WBUR's best health, medicine and science coverage. If you're 50 or older, Judith Strull's story ...

Please provide your email address to receive an email when new articles are posted on . The original formulation of Shingrix consists of two separate vials combined by health care workers prior to ...